Thus, in pregnant PGC-1α knockout mice, the 16 kDa prolactin-induced antiangiogenic effect and the inhibition of proangiogenic factors act together towards the development of a very severe form of peripartum cardiomyopathy. This evidence concerns the gene PPARGC1A and peripartum cardiomyopathy.